Coronary
Editorial Comment
Switching Oral Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention∗

https://doi.org/10.1016/j.jcin.2019.10.017Get rights and content
Under an Elsevier user license
open archive

Key Words

anticoagulant drug
atrial fibrillation
percutaneous coronary intervention
switch

Cited by (0)

Dr. Franchi has received honoraria from AstraZeneca and Sanofi. Dr. Rollini has reported that she has no relationships relevant to the contents of this paper to disclose.

∗

Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology.

© 2019 by the American College of Cardiology Foundation. Published by Elsevier.